Siwei Tan
Impact in
- Hepatology top 10%
- Liver physiology and pathology
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
Papers in
-
- Receptor Mechanisms and Signaling 4
-
- Liver Disease Diagnosis and Treatment 4
- Autophagy in Disease and Therapy 3
- Co-authors
- Jie Jiang (15 shared papers)Huiling Liu (14 shared papers)Bin Wu (7 shared papers)Jin Tao (5 shared papers)Yidong Yang (5 shared papers)Minyi Xu (5 shared papers)Fengping Zheng (3 shared papers)Bin Wu (10 shared papers)
In The Last Decade
Siwei Tan
26 papers receiving 922 citations
Siwei Tan's Hit Papers
Peers
Comparison fields: 5 of 84
- Hepatology 95
- Cancer Research 179
- Pulmonary and Respiratory Medicine 299
- Pharmacology 50
- Pharmacology 85
Countries citing papers authored by Siwei Tan
This map shows the geographic impact of Siwei Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siwei Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siwei Tan more than expected).
Fields of papers citing papers by Siwei Tan
This network shows the impact of papers produced by Siwei Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siwei Tan. The network helps show where Siwei Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Siwei Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ferroptosis involves in intestinal epithelial cell death in ulcerative colitis Hit paper breakdown → | 2020 | 325 |
| 2 | 2021 | 89 | |
| 3 | 2022 | 67 | |
| 4 | 2015 | 60 | |
| 5 | 2021 | 42 | |
| 6 | 2022 | 35 | |
| 7 | 2015 | 33 | |
| 8 | 2017 | 32 | |
| 9 | 2015 | 31 | |
| 10 | 2016 | 30 | |
| 11 | 2018 | 30 | |
| 12 | 2020 | 23 | |
| 13 | 2014 | 23 | |
| 14 | 2016 | 21 | |
| 15 | 2017 | 18 | |
| 16 | 2014 | 17 | |
| 17 | 2022 | 16 | |
| 18 | 2018 | 10 | |
| 19 | 2015 | 8 | |
| 20 | 2019 | 8 |
About Siwei Tan
Siwei Tan is a scholar working on Molecular Biology, Epidemiology, Hepatology, Pharmacology and Surgery, having authored 28 papers that have together received 928 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Receptor Mechanisms and Signaling (4 papers), Liver Disease and Transplantation (4 papers), Cancer, Stress, Anesthesia, and Immune Response (4 papers), Liver physiology and pathology (3 papers), Cannabis and Cannabinoid Research (3 papers), Berberine and alkaloids research (3 papers) and Autophagy in Disease and Therapy (3 papers). The work is most often cited by research in Hepatology (95 citations), Cancer Research (179 citations), Pulmonary and Respiratory Medicine (299 citations), Pharmacology (50 citations) and Pharmacology (85 citations). Siwei Tan has collaborated with scholars based in China and Norway. Frequent co-authors include Jie Jiang, Huiling Liu, Bin Wu, Jin Tao, Yidong Yang, Minyi Xu, Fengping Zheng, Bin Wu, Xing Wang and Xianzhi Liu. Their work appears in journals such as Cell Death and Disease, British Journal of Pharmacology, The FASEB Journal, Hepatology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.